{"id":20204,"date":"2024-05-28T14:47:56","date_gmt":"2024-05-28T14:47:56","guid":{"rendered":"https:\/\/organonpro.com\/es-es\/?post_type=news&#038;p=20204"},"modified":"2026-01-27T13:04:52","modified_gmt":"2026-01-27T13:04:52","slug":"cardiovascular-risk-and-myocardial-hypertrophy","status":"publish","type":"news","link":"https:\/\/organonpro.com\/es-es\/news\/cardiovascular-risk-and-myocardial-hypertrophy\/","title":{"rendered":"Association of cardiovascular risk factors and myocardial hypertrophy in women with preeclampsia history"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><em>Ricardo Mattos Ferreira, Fabiane Valentini Francisqueti Ferron, Vera Therezinha Medeiros Borges, Jos\u00e9 Carlos Pera\u00e7oli, Artur Junio Togneri Ferron, Meliza Goi Roscani, Jo\u00e3o Carlos Hueb, Rodrigo Bazan, Luis Cuadrado Martin, Silm\u00e9ia Garcia Zanati Bazan.&nbsp;<\/em><strong><em>Life Sciences<\/em><\/strong><em>. 2024 Jun 1:346:122646. doi: 10.1016\/j.lfs.2024.122646.<\/em><\/p>\n\n\n\n<div style=\"height:40px\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Puntos clave:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Estudio observacional prospectivo<\/strong>&nbsp;con el objetivo de&nbsp;<strong>evaluar la prevalencia de miocardiopat\u00eda hipertr\u00f3fica en mujeres j\u00f3venes<\/strong>&nbsp;(29 \u00b1 6,8 a\u00f1os) 12 meses&nbsp;<strong>despu\u00e9s<\/strong>&nbsp;de un evento&nbsp;<strong>de<\/strong>&nbsp;<strong>preeclampsia<\/strong>, as\u00ed como intentar identificar los factores de riesgo.<\/li>\n\n\n\n<li>Se incluyeron 118 pacientes de un \u00fanico centro de las que&nbsp;<strong>se evaluaron diversas variables<\/strong>: historia cl\u00ednica relacionada con eventos cardiovasculares, ecocardiograma, antecedentes gestacionales, datos demogr\u00e1ficos, peso, talla, tensi\u00f3n arterial y otros par\u00e1metros de laboratorio como colesterol y triglic\u00e9ridos.<\/li>\n\n\n\n<li>Se identific\u00f3&nbsp;<strong>hipertensi\u00f3n arterial en el 44% de pacientes, sobrepeso u obesidad en el 69% y s\u00edndrome metab\u00f3lico en el 40%.&nbsp;<\/strong><\/li>\n\n\n\n<li>Se observ\u00f3 que&nbsp;<strong>la hipertrofia ventricular era prevalente en mujeres j\u00f3venes con antecedentes de preeclampsia, que estaba asociada a la presencia de obesidad<\/strong>. Esta conclusi\u00f3n abre una ventana terap\u00e9utica para reducir el alto riesgo observado en este grupo de pacientes.<\/li>\n<\/ul>\n\n\n\n<div style=\"height:40px\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Enlace al art\u00edculo completo:&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38614304\/\">Association of cardiovascular risk factors and myocardial hypertrophy in women with preeclampsia history &#8211; PubMed (nih.gov)<\/a><\/p>\n\n\n\n<div style=\"height:40px\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Este contenido estar\u00e1 disponible hasta el\u00a0<strong>28 de mayo de 2029<\/strong>.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ricardo Mattos Ferreira, Fabiane Valentini Francisqueti Ferron, Vera Therezinha Medeiros Borges, Jos\u00e9 Carlos Pera\u00e7oli, Artur Junio Togneri Ferron, Meliza Goi Roscani, Jo\u00e3o Carlos Hueb, Rodrigo Bazan, Luis Cuadrado Martin, Silm\u00e9ia Garcia Zanati Bazan.&nbsp;Life Sciences. 2024 Jun 1:346:122646. doi: 10.1016\/j.lfs.2024.122646. Puntos clave: Enlace al art\u00edculo completo:&nbsp;Association of cardiovascular risk factors and myocardial hypertrophy in women with [&hellip;]<\/p>\n","protected":false},"author":120,"featured_media":20213,"parent":0,"menu_order":0,"template":"","meta":{"_acf_changed":false},"tags":[],"news_categories":[215,214],"class_list":["post-20204","news","type-news","status-publish","has-post-thumbnail","hentry","news_categories-atencion-primaria","news_categories-cardiologia"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Association of cardiovascular risk factors and myocardial hypertrophy in women with preeclampsia history - Organon Pro - Espa\u00f1a<\/title>\n<meta name=\"description\" content=\"Hay evidencia de que la preeclampsia est\u00e1 asociada con el desarrollo de enfermedades cardiovasculares en las mujeres. Este estudio arroja m\u00e1s evidencia al respecto.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/organonpro.com\/es-es\/news\/cardiovascular-risk-and-myocardial-hypertrophy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Association of cardiovascular risk factors and myocardial hypertrophy in women with preeclampsia history\" \/>\n<meta property=\"og:description\" content=\"Hay evidencia de que la preeclampsia est\u00e1 asociada con el desarrollo de enfermedades cardiovasculares en las mujeres. Este estudio arroja m\u00e1s evidencia al respecto.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/organonpro.com\/es-es\/news\/cardiovascular-risk-and-myocardial-hypertrophy\/\" \/>\n<meta property=\"og:site_name\" content=\"Organon Pro - Espa\u00f1a\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/OrganonandCo\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-27T13:04:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2024\/05\/cadiovascular-preclampsia-thumbnail.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"676\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@OrganonLLC\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/news\\\/cardiovascular-risk-and-myocardial-hypertrophy\\\/\",\"url\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/news\\\/cardiovascular-risk-and-myocardial-hypertrophy\\\/\",\"name\":\"Association of cardiovascular risk factors and myocardial hypertrophy in women with preeclampsia history - Organon Pro - Espa\u00f1a\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/news\\\/cardiovascular-risk-and-myocardial-hypertrophy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/news\\\/cardiovascular-risk-and-myocardial-hypertrophy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/wp-content\\\/uploads\\\/sites\\\/11\\\/2024\\\/05\\\/cadiovascular-preclampsia-thumbnail.jpg\",\"datePublished\":\"2024-05-28T14:47:56+00:00\",\"dateModified\":\"2026-01-27T13:04:52+00:00\",\"description\":\"Hay evidencia de que la preeclampsia est\u00e1 asociada con el desarrollo de enfermedades cardiovasculares en las mujeres. Este estudio arroja m\u00e1s evidencia al respecto.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/news\\\/cardiovascular-risk-and-myocardial-hypertrophy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/organonpro.com\\\/es-es\\\/news\\\/cardiovascular-risk-and-myocardial-hypertrophy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/news\\\/cardiovascular-risk-and-myocardial-hypertrophy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/wp-content\\\/uploads\\\/sites\\\/11\\\/2024\\\/05\\\/cadiovascular-preclampsia-thumbnail.jpg\",\"contentUrl\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/wp-content\\\/uploads\\\/sites\\\/11\\\/2024\\\/05\\\/cadiovascular-preclampsia-thumbnail.jpg\",\"width\":1200,\"height\":676},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/news\\\/cardiovascular-risk-and-myocardial-hypertrophy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Association of cardiovascular risk factors and myocardial hypertrophy in women with preeclampsia history\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/#website\",\"url\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/\",\"name\":\"Organon Pro - Espa\u00f1a\",\"description\":\"Organon Pro - Espa\u00f1a\",\"publisher\":{\"@id\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/#organization\",\"name\":\"Organon Pro - Espa\u00f1a\",\"url\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/wp-content\\\/uploads\\\/sites\\\/11\\\/2023\\\/08\\\/organon-pro-1.webp\",\"contentUrl\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/wp-content\\\/uploads\\\/sites\\\/11\\\/2023\\\/08\\\/organon-pro-1.webp\",\"width\":2269,\"height\":243,\"caption\":\"Organon Pro - Espa\u00f1a\"},\"image\":{\"@id\":\"https:\\\/\\\/organonpro.com\\\/es-es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/OrganonandCo\",\"https:\\\/\\\/x.com\\\/OrganonLLC\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Association of cardiovascular risk factors and myocardial hypertrophy in women with preeclampsia history - Organon Pro - Espa\u00f1a","description":"Hay evidencia de que la preeclampsia est\u00e1 asociada con el desarrollo de enfermedades cardiovasculares en las mujeres. Este estudio arroja m\u00e1s evidencia al respecto.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/organonpro.com\/es-es\/news\/cardiovascular-risk-and-myocardial-hypertrophy\/","og_locale":"en_US","og_type":"article","og_title":"Association of cardiovascular risk factors and myocardial hypertrophy in women with preeclampsia history","og_description":"Hay evidencia de que la preeclampsia est\u00e1 asociada con el desarrollo de enfermedades cardiovasculares en las mujeres. Este estudio arroja m\u00e1s evidencia al respecto.","og_url":"https:\/\/organonpro.com\/es-es\/news\/cardiovascular-risk-and-myocardial-hypertrophy\/","og_site_name":"Organon Pro - Espa\u00f1a","article_publisher":"https:\/\/www.facebook.com\/OrganonandCo","article_modified_time":"2026-01-27T13:04:52+00:00","og_image":[{"width":1200,"height":676,"url":"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2024\/05\/cadiovascular-preclampsia-thumbnail.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@OrganonLLC","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/organonpro.com\/es-es\/news\/cardiovascular-risk-and-myocardial-hypertrophy\/","url":"https:\/\/organonpro.com\/es-es\/news\/cardiovascular-risk-and-myocardial-hypertrophy\/","name":"Association of cardiovascular risk factors and myocardial hypertrophy in women with preeclampsia history - Organon Pro - Espa\u00f1a","isPartOf":{"@id":"https:\/\/organonpro.com\/es-es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/organonpro.com\/es-es\/news\/cardiovascular-risk-and-myocardial-hypertrophy\/#primaryimage"},"image":{"@id":"https:\/\/organonpro.com\/es-es\/news\/cardiovascular-risk-and-myocardial-hypertrophy\/#primaryimage"},"thumbnailUrl":"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2024\/05\/cadiovascular-preclampsia-thumbnail.jpg","datePublished":"2024-05-28T14:47:56+00:00","dateModified":"2026-01-27T13:04:52+00:00","description":"Hay evidencia de que la preeclampsia est\u00e1 asociada con el desarrollo de enfermedades cardiovasculares en las mujeres. Este estudio arroja m\u00e1s evidencia al respecto.","breadcrumb":{"@id":"https:\/\/organonpro.com\/es-es\/news\/cardiovascular-risk-and-myocardial-hypertrophy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/organonpro.com\/es-es\/news\/cardiovascular-risk-and-myocardial-hypertrophy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/organonpro.com\/es-es\/news\/cardiovascular-risk-and-myocardial-hypertrophy\/#primaryimage","url":"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2024\/05\/cadiovascular-preclampsia-thumbnail.jpg","contentUrl":"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2024\/05\/cadiovascular-preclampsia-thumbnail.jpg","width":1200,"height":676},{"@type":"BreadcrumbList","@id":"https:\/\/organonpro.com\/es-es\/news\/cardiovascular-risk-and-myocardial-hypertrophy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/organonpro.com\/es-es\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/organonpro.com\/es-es\/news\/"},{"@type":"ListItem","position":3,"name":"Association of cardiovascular risk factors and myocardial hypertrophy in women with preeclampsia history"}]},{"@type":"WebSite","@id":"https:\/\/organonpro.com\/es-es\/#website","url":"https:\/\/organonpro.com\/es-es\/","name":"Organon Pro - Espa\u00f1a","description":"Organon Pro - Espa\u00f1a","publisher":{"@id":"https:\/\/organonpro.com\/es-es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/organonpro.com\/es-es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/organonpro.com\/es-es\/#organization","name":"Organon Pro - Espa\u00f1a","url":"https:\/\/organonpro.com\/es-es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/organonpro.com\/es-es\/#\/schema\/logo\/image\/","url":"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2023\/08\/organon-pro-1.webp","contentUrl":"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2023\/08\/organon-pro-1.webp","width":2269,"height":243,"caption":"Organon Pro - Espa\u00f1a"},"image":{"@id":"https:\/\/organonpro.com\/es-es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/OrganonandCo","https:\/\/x.com\/OrganonLLC"]}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/news\/20204","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/users\/120"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/media\/20213"}],"wp:attachment":[{"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/media?parent=20204"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/tags?post=20204"},{"taxonomy":"news_categories","embeddable":true,"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/news_categories?post=20204"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}